The future of oncologic medications is promising, with advancements in personalized medicine and genomic research. Researchers are developing drugs that are tailored to the genetic makeup of an individual's cancer, which could lead to more effective treatments with fewer side effects. Additionally, combination therapies that use multiple types of oncologic medications are being explored to improve outcomes.
